RxDoctor Payments Data

Sonja Hanson Fauchet, PA

Medical · Glenwood Springs, CONPI 1821438961

Payments from drug & device makers

$1,744in general payments, 2019–2025

Across 31 payments — averaging $56.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$100
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$64
  • E.r. Squibb & Sons, L.L.C.$58
  • Novartis$52
  • AstraZeneca$35
  • plus $120 from 4 others

What the payments were for

  • Grants$1006%
  • Travel & lodging$91252%
  • Food & beverage$73242%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,744 in reported general payments places this provider in the 75th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$39,957
Medicare patients
367
Services billed
892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban180$216,221
XareltoRivaroxaban61$73,662
Repatha SureclickEvolocumab30$21,449
EntrestoSacubitril/Valsartan13$18,828
FarxigaDapagliflozin Propanediol13$14,706
Dofetilide41$2,976
Eplerenone19$2,572
Nebivolol Hcl22$2,152
Flecainide Acetate37$1,609
Propafenone Hcl18$1,540
Rosuvastatin Calcium85$1,462
Metoprolol Succinate111$1,412
Diltiazem 24hr Er (Cd)Diltiazem Hcl44$1,202
Spironolactone118$1,181
Atorvastatin Calcium105$1,124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$52$18,82813 claims
AstraZenecaFarxiga$35$14,70613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 766 medical providers in Colorado.

Other medical in Glenwood Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →